Spetzler; Jane
Patent Applications and Registrations
Patent applications and USPTO patent grants for Spetzler; Jane.The latest application filed is for "glucose sensitive insulin derivatives".
Company Profile
1.19.35
- Spetzler; Jane - Broenshoej DK
- Spetzler; Jane - Bronshoj DK
- SPETZLER; JANE - COPENHAGEN O DK
- Spetzler; Jane - Bagsvaerd DK
- Spetzler; Jane - Copenhagen DK
- Spetzler; Jane - 2100-DK Copenhagen .O slashed. DK
Patent Activity
| Patent | Date |
|---|---|
| Glucose Sensitive Insulin Derivatives App 20220184184 - Hoeg-Jensen; Thomas ; et al. | 2022-06-16 |
| Double-acylated GLP-1 derivatives Grant 11,117,947 - Wieczorek , et al. September 14, 2 | 2021-09-14 |
| Compounds Capable of Binding to Melanocortin 4 Receptor App 20210221867 - Frieboes; Kilian Waldemar Conde ; et al. | 2021-07-22 |
| Double-acylated GLP-1 derivatives Grant 11,034,746 - Wieczorek , et al. June 15, 2 | 2021-06-15 |
| Double-acylated Glp-1 Derivatives App 20200079834 - Wieczorek; Birgit ; et al. | 2020-03-12 |
| Double-Acylated GLP-1 Derivatives App 20180251512 - Wieczorek; Birgit ; et al. | 2018-09-06 |
| Double-acylated GLP-1 derivatives Grant 10,005,827 - Spetzler , et al. June 26, 2 | 2018-06-26 |
| Stable GLP-1 based GLP-1/glucagon receptor co-agonists Grant 9,988,430 - Reedtz-Runge , et al. June 5, 2 | 2018-06-05 |
| Double-acylated GLP-1 derivatives Grant 9,708,383 - Madsen , et al. July 18, 2 | 2017-07-18 |
| Truncated GLP-1 derivatives and their therapeutical use Grant 9,657,079 - Spetzler , et al. May 23, 2 | 2017-05-23 |
| Double-Acylated GLP-1 Derivatives App 20170058014 - Wieczorek; Birgit ; et al. | 2017-03-02 |
| Double-acylated GLP-1 derivatives Grant 9,556,250 - Garibay , et al. January 31, 2 | 2017-01-31 |
| Glucagon-like peptide-1 derivatives and their pharmaceutical use Grant 9,409,966 - Spetzler , et al. August 9, 2 | 2016-08-09 |
| Stable GLP-1 Based GLP-1/Glucagon Receptor Co-Agonists App 20160102129 - Reedtz-Runge; Steffen ; et al. | 2016-04-14 |
| Double-acylated Glp-1 Derivatives App 20160083447 - Wieczorek; Birgit ; et al. | 2016-03-24 |
| Multi-substituted insulins Grant 9,260,503 - Hoeg-Jensen , et al. February 16, 2 | 2016-02-16 |
| Peptides derivatized with A-B-C-D- and their therapeutical use Grant 9,067,977 - Spetzler , et al. June 30, 2 | 2015-06-30 |
| Acylated exendin-4 compounds Grant 9,012,398 - Lau , et al. April 21, 2 | 2015-04-21 |
| Glucagon-like Peptide-1 Derivatives And Their Pharmaceutical Use App 20150025003 - Spetzler; Jane ; et al. | 2015-01-22 |
| Glucagon-Like Peptide-1 derivatives and their pharmaceutical use Grant 8,895,694 - Spetzler , et al. November 25, 2 | 2014-11-25 |
| Truncated GLP-1 Derivatives and Their Therapeutical Use App 20140296131 - Spetzler; Jane ; et al. | 2014-10-02 |
| GLP-1 analogues and derivatives Grant 8,815,802 - Kalthoff , et al. August 26, 2 | 2014-08-26 |
| Multi-Substituted Insulins App 20140228285 - Hoeg-Jensen; Thomas ; et al. | 2014-08-14 |
| Double-acylated Glp-1 Derivatives App 20140179899 - Garibay; Patrick William ; et al. | 2014-06-26 |
| Double-acylated Glp-1 Derivatives App 20140088005 - Wieczorek; Birgit ; et al. | 2014-03-27 |
| Peptides Derivatized with A-B-C-D- and their Therapeutical Use App 20140011732 - Spetzler; Jane ; et al. | 2014-01-09 |
| Double-Acylated GLP-1 Derivatives App 20130288960 - Madsen; Alice Ravn ; et al. | 2013-10-31 |
| Glp-1 Analogues And Derivatives App 20130053311 - Kalthoff; Christoph ; et al. | 2013-02-28 |
| Peptides for Treatment of Obesity App 20130012432 - Conde-Frieboes; Kilian Waldemar ; et al. | 2013-01-10 |
| Acylated Exendin-4 Compounds App 20120283170 - Lau; Jesper ; et al. | 2012-11-08 |
| Long-Acting Y2 and/or Y4 Receptor Agonists App 20110275559 - Ostergaard; Soren ; et al. | 2011-11-10 |
| Double-acylated Glp-1 Derivatives App 20110166321 - GARIBAY; PATRICK WILLIAM ; et al. | 2011-07-07 |
| Insulin and IGF-1 Receptor Agonists and Antagonists App 20110124556 - PILLUTLA; RENUKA ; et al. | 2011-05-26 |
| Glucagon-like Peptide-1 Derivatives And Their Pharmaceutical Use App 20110082079 - Spetzler; Jane ; et al. | 2011-04-07 |
| Igf-1r Binding Proteins And Antagonists App 20110039779 - Ostergaard; Soren ; et al. | 2011-02-17 |
| Truncated Glp-1 Derivaties And Their Therapeutical Use App 20100292133 - Spetzler; Jane ; et al. | 2010-11-18 |
| Peptides Derivatized With A-b-c-d- And Their Therapeutical Use App 20100261637 - Spetzler; Jane ; et al. | 2010-10-14 |
| Novel Peptides for Use in the Treatment of Obesity App 20100016237 - Sensfuss; Ulrich ; et al. | 2010-01-21 |
| Acylated Exendin-4 Compounds App 20090318353 - Lau; Jesper ; et al. | 2009-12-24 |
| Novel Peptides for Use in the Treatment of Obesity App 20090203581 - Sensfuss; Ulrich ; et al. | 2009-08-13 |
| Insulin and IGF-1 Receptor Agonists and Antagonists App 20090192072 - Pillutla; Renuka ; et al. | 2009-07-30 |
| Dimeric Peptide Agonists of the Glp-1 Receptor App 20090062192 - Christensen; Leif ; et al. | 2009-03-05 |
| Insulin And Igf-1 Receptor Agonists And Antagonists App 20070265189 - Pillutla; Renuka ; et al. | 2007-11-15 |
| Insulin and IGF-1 receptor agonists and antagonists Grant 6,875,741 - Pillutla , et al. April 5, 2 | 2005-04-05 |
| Isulin and IGF-1 receptor agonists and antagonists App 20030236190 - Pillutla, Renuka ; et al. | 2003-12-25 |
| Insulin and IGF-1 receptor agonists and antagonists App 20030195147 - Pillutla, Renuka ; et al. | 2003-10-16 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 